MDM4 and esophageal cancer: A meta-analysis of 15 studies and over 69,000 subjects found an overall inverse association between MDM4 rs4245739*C and risk for breast, ovarian, endometrial, lung, colon, esophageal cancer, prostate, and non-Hodgkin’s lymphoma [53].